Autosomal Dominant Flashcards

week 6

1
Q

expression

A

Severity or mildness of phenotype

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What is expression influenced by?

A

environmental factors and allelic variants in other genes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Penetrance

A

Chance that an individual will actully develop symptoms

Partial = alleles manifest a phenotype in some

Full = 100% chance

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What are the 4 types of mutated allele classifications (in terms of functional affect)

A

Hylomorphic – produces protein with reduced activity

Neuromorphic – produces protein with new activity or product

Antimorphic – antagonizes the activity of normal gene product

Hypermorphic- produces protein with increased activity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Features of autosomal dominant inheritance

A

Vertical degree pattern

Multiple generations affected

Each person normally has an affected parent

Male and females equally affected

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Chances of affected child for:

Hetero disease x hetero disease =

Homo disease x homo health =

Hetero disease x homo healthy =

A

75%

100%

50%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Expression repeat disorders

A

Dynamic mutation in which there is an increase in the number of repeats in a tri DNA seq.

Causes improper protein function

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

How does slipping and miss paring in DNA replication = increase in repeats

A
  • backwards slippage
  • repeat expansion = hairpin
  • hairpin repeats incorporated
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What does Knudsib’s two-hit hypothesis propose about how diseases are inherited?

A

Familial = inherit a mutation, 2nd develops somatically

Sporadic = 2 somatic mutations

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Rationale and testing strategy for pre-symptomatic testing.

A

Test affected family member for specific mutation

Confirm diagnosis of family member at risk ( if treatment is avalaible)

Offer pre-symptomatic testing or asses risk for recurrence

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Why is gene therapy better for recessive traits? How can it be used in AD?

A

replaces nonfunctioning genes with a correct function

for AD = antisense RNA inhibition of gene expression

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

explain the use of gene therapy for AD diseases.

A
  1. start with antisense siRNA complementary to an mRNA target region
  2. siRNA foms a complex that recognises target region
  3. target region is cleaved
  4. loss of protein synthesis (loss of function)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What is the gene affected in Achondroplasia and Hypochondroplasia and what is the normal function of it?

A

FGFR3

codes for a tyrosine kinase receptor that signals growth

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What is the common cause of the muation in achondroplasia and hypocondroplasia?

A

De novo during embryogenesis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What is the effect of achondroplasia and hypochondraplasia on cell function?

A
  • gain of function
    -inhibition of proliferation and hypertrophy of chondrocytes on growth plate
    -decreased echnodnral classification
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Reproductive expression of disease for Herero vs homo parents with achondropalsia.

A

If 2 hetero reproduce:
-2/3 dwarfism
1/3 normal

Homozygosity of mutant = incompatible of life.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

clinical features of Achondroplasia

A

Abnormal bone growth
Short stature
Large head
disproportionate limb trunks

18
Q

With achondroplasia, why is there is an increased risk of death in infancy?

A

spinal cord compression/ upper airway obstruction (bone does not grow wide enough)

19
Q

Affected gene, mutation and impact on cell level for hypochondroplasia

A

Gene
FGFR3

Mutations
p.ANS540Lys
p.Lys650Met

Gain of function –> decreased endochondral ossification, inhibited chondrocyte proliferation in growth plate and decerased cartlidge matrix production

LESS SEVERE

20
Q

Clinical features of hypochodroplasia

A

Normal birth and weigth

Disproportionate limb trunk length

Presents as toddlers

Short stature disproportionate to limbs as age

21
Q

Achondroplasia vs hypochondrial clinical presentations.

A

Hypo= NO trident hands or facail features

Hypo = normal motor milestones

22
Q

Affected gene, mutation and effect on phenotype for Huntingtion’s disease.

A

Gene
-HTT gene
Mutation
-CAG repeat in HTT protein
Phenotype
-HTT protein aggregation on cells = atrophy

23
Q

Huntington’s disease clinical features

A

Progressive motor disability

Chorea (jerky involuntary movements)

Cognitive decline

Mental disturbance

Changes in personality

onset depends on number of repeats
Adult onset = 40-55 repeats

Juvenile onset = greater than 60 repeats

24
Q

Penetrance of Huntington’s

A

need more than 40 repeats for be 100%

24
Q

How many repeats of CAG in a person with vs without Huntington’s disease?

A

Normal person = 10-26

Affected= 36-121

25
Q

Anticipation

A

phenomenon in which there is increase disease severity and/ or earlier age of onset in successive generations

26
Q

Treatment of HD.

A

None

Potential for gene therapy

27
Q

What are the three phenotypes of mytonic dystrophy and what determines their expression?

A

3 phenotypic affects
-mild
-classic
-congineital

Changes from M-C depending on increasing CTG repeats, decreased age of onset and decreased life Expectancy

27
Q

Affected gene, mutation and penetrance of Myotonic dystrophy

A

Gene
-DMPK

Mutation
-more than 37 CTG repeats

Penetrance
-need more than 50 for 100%

28
Q

What organs are affected by myotonic dystrophy?

A

Skeletal
Eyes
Endocrine
CNS

29
Q

Mangement of Myotonic dystrophy

A

assistive devices (wheelchairs etc)

-symptomatic treatment:
-hypothyroidism, pain management arrythmia etc

30
Q

Genetic deficit and mutated function i retinoblastoma.

A

Deficit
Loss of function in tumor suppressor gene / RB1

Mutated function
-loss of inhibiting function = uncontrolled cell cycle progression

31
Q

Main clinical feature of Retinoblastoma

A

Leukocria (white pupils, clearer in photos).

32
Q

Inheritance patterns of Retinoblastoma

A

Inheritance patterns:
Familial or sporadic

Due to loss of function on alleles on RB gene

33
Q

Life expectancy and inheritance pattern of neurofibromatosis

A

Inheritance pattern
Knudosons 2-hit hypothesis

Lifespan
-NF1= 8 years lower
-NF2- normal

34
Q

Gene locus, Clinical features and treament for NG1

A

Gene locus NF1
17q12

clinical features
Changes in pigmentation
Growth of tumors along nerves in skin/brain

treatment
Surgical removal of disfiguring cutaneous or sub cutaneous neurofibrils

35
Q

Gene locus, Clinical features and treament for NG2

A

gene locus
22qq12.2

clinical features
Growth of noncancerous tumours in nervous system = hearing loss and deafness

Vestibular growth schwannomas

treatment
Surgical removal of vesicular schwannomas

Awareness of problems with balance and underwater disorientation

36
Q

What are the affected genes of PKD and what is the percentage contribution from each of them?

A

PKD1 = 85%

PKD2 = 15%

37
Q

Clinical manifestations of Polyccystic Kidney Disease.

A

The most common clinical presentations are hypertension, anemia, liver cysts, hematuria, flank pain, abdominal masses, urinary tract infections, renal failure, nephrolithiasis, and renal cancer

38
Q

genetic diversity

A

The difference in the way that signs and symptoms of a genetic condition can show up in individual patients who have that condition